期刊文献+

硫化氢:中枢神经系统的新型神经调质和保护剂 被引量:1

A new neuromodulator and neuroprotectant of the central nervous system: hydrogen sulfide
原文传递
导出
摘要 硫化氢(H_2S)作为一种有毒气体被人们所熟识,但目前,越来越多的证据表明H_2S亦是生物系统中的一种活性分子。H_2S在大脑有相对较高的表达,发挥着重要的生理、病理功能。它能通过影响N-甲基-D-天冬氨酸(NMDA)受体和第二信使系统[包括细胞内Ca^(2+)浓度和细胞内环磷酸腺苷(c AMP)水平等]来调节神经传导;而作为一种神经保护剂,它在病理状态下具有抗氧化、抗炎、抗凋亡的作用;并且,在一些中枢神经系统疾病中显示潜在的治疗价值,包括阿尔茨海默病、帕金森病、缺血性卒中和创伤性脑损伤。靶蛋白的硫巯基化修饰是这些作用的一个重要机制。本文总结了目前H_2S在中枢神经系统中的研究进展,强调其作为神经调质和神经保护剂的作用。 Hydrogen sulfide (H2 S)used to be known as a toxicgas. However,in the last two decades, accumulating evidences have revealed its role as a bioactive molecule in the biological systems. H2 S has relatively high expression in the brain ,exerting multiple functions in both health and diseases. It modulates neurotransmission by influencing behaviors of N-metbyl-D-aspartic acid (NMDA) receptors and second messenger systems including intracellular Ca2 ~ concentration and intracellular cyclic adenosine monophosphate(cAMP) levels and so forth. As a neuroprotectant, H2 S produces antioxidant and has the anti- inflammatory and antiapoptotic effects in pathological situations. H2S shows potential therapeutic value in several central nervous system(CNS) diseases including Alzheimer's disease, Parkinson's disease, ischemic stroke, and traumatic brain injury. Sulfhydration of target proteins is an important mechanism underlying these effects. This review summarized the current understanding of H2 S in the CNS,with emphasis on its role as a new neuromodulator and a neuroprotectant.
出处 《中华脑科疾病与康复杂志(电子版)》 2016年第1期60-64,共5页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
基金 北京协和医学基金-睿E(睿意)急诊医学科研专项基金(R2014012)
关键词 硫化氢 神经保护药 中枢神经系统 神经调质 Hydrogen sulfide Nearoprotective agents Central nervous system Neuromodulation
  • 相关文献

参考文献1

二级参考文献21

  • 1耿彬,常林,杜军保,唐朝枢.防治高同型半胱氨酸血症的新策略[J].北京大学学报(医学版),2005,37(2):215-219. 被引量:38
  • 2耿彬,杜军保,唐朝枢北京大学第一医院心血管研究所.敏感硫电极法在测定心血管组织细胞及血浆胱硫醚-γ-裂解酶/硫化氢的应用[J].北京大学学报(医学版),2005,37(5):545-548. 被引量:85
  • 3刘祥琴,晏勇.神经系统中内源性硫化氢的研究进展[J].生理科学进展,2007,38(2):177-180. 被引量:8
  • 4Takashi K, Kazunori I, Hitoshi T. Are cerebrovascular factors involved in Alzbeimer's disease. Neurobiol Aging, 2001, 21: 1215-1224.
  • 5Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging, 2000, 21:321-330.
  • 6McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzhelmer's Disease. Neurology, 1984, 34:939-944.
  • 7Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43 : 250-260.
  • 8Eto K, Asada T, Arima K, et al. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun, 2002, 293 : 1485-1488.
  • 9Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite “scavenger”? Neuroehem, 2004, 90:765-768.
  • 10Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal, 2003, 5:493-501.

共引文献27

同被引文献18

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部